Nonsustained ventricular tachycardia

Journal of the American College of Cardiology

Volumn 60, Issue 20, 2012, Pages 1993-2004

  Katritsis, Demosthenes G ^a   Zareba, Wojciech ^b   Camm, A John ^c  

^a Athens Euroclinic   (Greece)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

nonsustained; tachycardia; unsustained; ventricular

Indexed keywords

AMIODARONE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FLECAINIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SOTALOL;

ACUTE HEART INFARCTION; ATHLETE; CARDIOMYOPATHY; CARDIOVASCULAR RISK; CHANNELOPATHY; CLINICAL ASSESSMENT; CONGESTIVE CARDIOMYOPATHY; DEFIBRILLATION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPH; EXERCISE; GENETIC DISORDER; HEART INFARCTION; HEART LEFT BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART MUSCLE REVASCULARIZATION; HEART RIGHT BUNDLE BRANCH BLOCK; HEART RIGHT VENTRICLE OUTFLOW TRACT; HEART VENTRICLE TACHYCARDIA; HIGH RISK PATIENT; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; HYPERTROPHIC CARDIOMYOPATHY; IDIOPATHIC DISEASE; ISCHEMIC HEART DISEASE; MONOMORPHIC VENTRICULAR TACHYCARDIA; MORTALITY; NON ST SEGMENT ELEVATION ACUTE CORONARY SYNDROME; NONHUMAN; NONSUSTAINED VENTRICULAR TACHYCARDIA; POLYMORPHIC VENTRICULAR TACHYCARDIA; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; QRS COMPLEX; RADIOFREQUENCY ABLATION; REVIEW; SUDDEN DEATH;

CARDIOMYOPATHY, HYPERTROPHIC; DEATH, SUDDEN, CARDIAC; HUMANS; MYOCARDIAL ISCHEMIA; PROGNOSIS; RISK FACTORS; TACHYCARDIA, VENTRICULAR;

EID: 84868518595     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2011.12.063     Document Type: Review

References (142)

1. D.G. Katritsis, A.J. Camm Nonsustained ventricular tachycardia: where do we stand? Eur Heart J 25 2004 1093 1099
2. P.E. Bloch Thomsen, C. Jons, M.J. Raatikainen Long-term recording of cardiac arrhythmias with an implantable cardiac monitor in patients with reduced ejection fraction after acute myocardial infarction: the Cardiac Arrhythmias and Risk Stratification After Acute Myocardial Infarction (CARISMA) study Circulation 122 2010 1258 1264
3. W. Grimm, M. Christ, J. Bach, H.H. Müller, B. Maisch Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg cardiomyopathy study Circulation 108 2003 2883 2891
4. A.C. Caruso, F.I. Marcus, E.A. Hahn, V.L. Hartz, J.W. Mason Predictors of arrhythmic death and cardiac arrest in the ESVEM trial Electrophysiologic Study Versus Electromagnetic Monitoring Circulation 96 1997 1888 1892
5. J.R. Teerlink, M. Jalaluddin, S. Anderson Ambulatory ventricular arrhythmias in patients with heart failure do not specifically predict an increased risk of sudden death PROMISE (Prospective Randomized Milrinone Survival Evaluation) Investigators Circulation 101 2000 40 46
6. J.C. Senges, R. Becker, K.D. Schreiner Variability of Holter electrocardiographic findings in patients fulfilling the noninvasive MADIT criteria Multicenter Automatic Defibrillator Implantation Trial Pacing Clin Electrophysiol 25 2002 183 190
7. M. Bikkina, M.G. Larson, D. Levy Prognostic implications of asymptomatic ventricular arrhythmias: the Framingham heart study Ann Int Med 117 1992 990 996
8. M. Bikkina, M.G. Larson, D. Levy Asymptomatic ventricular arrhythmias and mortality risk in subjects with left ventricular hypertrophy J Am Coll Cardiol 22 1993 1111 1116
9. G. Engstrom, B. Hedblad, L. Janzon Ventricular arrhythmias during 24-h ambulatory ECG recording: incidence, risk factors and prognosis in men with and without a history of cardiovascular disease J Intern Med 246 1999 363 372
10. X. Jouven, M. Zureik, M. Desnos, D. Courbon, P. Ducimetiere Long-term outcome in asymptomatic men with exercise-induced premature ventricular depolarizations N Engl J Med 343 2000 826 833
11. J.P. Frolkis, C.E. Pothier, E.H. Blackstone, M.S. Lauer Frequent ventricular ectopy after exercise as a predictor of death N Engl J Med 348 2003 781 790
12. A. Biffi, A. Pelliccia, L. Verdile Long-term clinical significance of frequent and complex ventricular tachyarrhythmias in trained athletes J Am Coll Cardiol 40 2002 446 452
13. S. Baldesberger, U. Bauersfeld, R. Candinas Sinus node disease and arrhythmias in the long-term follow-up of former professional cyclists Eur Heart J 29 2008 71 78
14. A. Biffi, B.J. Maron, B. Di Giacinto Relation between training-induced left ventricular hypertrophy and risk for ventricular tachyarrhythmias in elite athletes Am J Cardiol 101 2008 1792 1795
15. A. Biffi, B.J. Maron, L. Verdile Impact of physical deconditioning on ventricular tachyarrhythmias in trained athletes J Am Coll Cardiol 44 2004 1053 1058
16. A. Biffi, B.J. Maron, F. Culasso Patterns of ventricular tachyarrhythmias associated with training, deconditioning and retraining in elite athletes without cardiovascular abnormalities Am J Cardiol 107 2011 697 703
17. B. Surawicz, P.W. Macfarlane Inappropriate and confusing electrocardiographic terms J-wave syndromes and early repolarization J Am Coll Cardiol 57 2011 1584 1586
18. C. Antzelevitch, G.X. Yan J wave syndromes Heart Rhythm 7 2010 549 558
19. J.T. Tikkanen, O. Anttonen, M.J. Junttila Long-term outcome associated with early repolarization on electrocardiography N Engl J Med 361 2009 2529 2537
20. M. Haissaguerre, N. Derval, F. Sacher Sudden cardiac arrest associated with early repolarization N Engl J Med 358 2008 2016 2023
21. H. Watanabe, T. Makiyama, T. Koyama High prevalence of early repolarization in short QT syndrome Heart Rhythm 7 2010 647 652
22. R. Cappato, F. Furlanello, V. Giovinazzo J wave, QRS slurring, and ST elevation in athletes with cardiac arrest in the absence of heart disease: marker of risk or innocent bystander? Circ Arrhythm Electrophysiol 3 2010 305 311
23. J.T. Tikkanen, M.J. Junttila, O. Anttonen Early repolarization: electrocardiographic phenotypes associated with favorable long-term outcome Circulation 123 2011 2666 2673
24. S.E. Lehnart, M.J. Ackerman, D.W. Benson Jr. Inherited arrhythmias: a National Heart, Lung, and Blood Institute and Office of Rare Diseases workshop consensus report about the diagnosis, phenotyping, molecular mechanisms, and therapeutic approaches for primary cardiomyopathies of gene mutations affecting ion channel function Circulation 116 2007 2325 2345
25. D. Katritsis, J. Gill, A.J. Camm Repetitive monomorphic ventricular tachycardia D.P. Zipes, J. Jalife, Clinical Electrophysiology: From Cell to Bedside 2nd edition 1995 Saunders Philadelphia, PA 900 906
26. R.J. Kim, S. Iwai, S.M. Markowitz, B.K. Shah, K.M. Stein, B.B. Lerman Clinical and electrophysiological spectrum of idiopathic ventricular outflow tract arrhythmias J Am Coll Cardiol 49 2007 2035 2043
27. A.E. Buxton, F.E. Marschlinski, J.U. Doherty Repetitive monomorphic ventricular tachycardia: clinical and electrophysiologic characteristics in patients with and patients without organic heart disease Am J Cardiol 54 1984 997 1002
28. F. Ouyang, P. Fotuhi, S.Y. Ho Repetitive monomorphic ventricular tachycardia originating from the aortic sinus cusp: electrocardiographic characterization for guiding catheter ablation J Am Coll Cardiol 39 2002 500 508
29. F.I. Marcus, W.J. McKenna, D. Sherrill Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria Eur Heart J 31 2010 806 814
30. M.D. Carlson, R.D. White, R.G. Trohman Right ventricular outflow tract ventricular tachycardia: detection of previously unrecognized anatomic abnormalities using cine magnetic resonance imaging J Am Coll Cardiol 24 1994 720 727
31. C. Chimenti, F. Calabrese, G. Thiene, M. Pieroni, A. Maseri, A. Frustaci Inflammatory left ventricular microaneurysms as a cause of apparently idiopathic ventricular tachyarrhythmias Circulation 104 2001 168 173
32. K.S. Hoffmayer, O.N. Machado, G.M. Marcus Electrocardiographic comparison of ventricular arrhythmias in patients with arrhythmogenic right ventricular cardiomyopathy and right ventricular outflow tract tachycardia J Am Coll Cardiol 58 2011 831 838
33. W. Shimizu Arrhythmias originating from the right ventricular outflow tract: how to distinguish "malignant" from "benign"? Heart Rhythm 6 2009 1507 1511
34. Z. Blanck, M. Jazayeri, A. Dhala, S. Deshpande, J. Sra, M. Akhtar Bundle branch reentry: a mechanism of ventricular tachycardia in the absence of myocardial or valvular dysfunction J Am Coll Cardiol 22 1993 1718 1722
35. D. Katritsis, A. Ahsan, M. Anderson Catheter ablation for successful management of fascicular tachycardia An approach guided by the recording of fascicular potentials Heart 75 1996 384 388
36. F. Ouyang, R. Cappato, S. Ernst Electroanatomic substrate of idiopathic left ventricular tachycardia: unidirectional block and macroreentry within the Purkinje network Circulation 105 2002 462 469
37. R.J. Myerburg, K.M. Kessler, M.M. Cox Reversal of proarrhythmic effects of flecainide acetate and encainide hydrochloride by propranolol Circulation 80 1989 1571 1579
38. W.G. Stevenson, K. Soejima Catheter ablation for ventricular tachycardia Circulation 115 2007 2750 2760
39. C. Antzelevitch, P. Brugada, M. Borggrefe Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association Circulation 111 2005 659 670
40. W. Zareba, A.J. Moss, S. le Cessie Risk of cardiac events in long QT syndrome family members J Am Coll Cardiol 26 1995 1685 1691
41. H. Morita, J. Wu, D.P. Zipes The QT syndromes: long and short Lancet 372 2008 750 763
42. A. Leenhardt, E. Glaser, M. Burguera, M. Nurnberg, P. Maison-Blanche, P. Coumel Short-coupled variant of torsade de pointes: a new electrocardiographic entity in the spectrum of idiopathic ventricular tachyarrhythmias Circulation 89 1993 206 215
43. I. Goldenberg, J. Bradley, A. Moss Beta-blocker efficacy in high-risk patients with the congenital long-QT syndrome types 1 and 2: implications for patient management J Cardiovasc Electrophysiol 21 2010 893 901
44. S.G. Priori, C. Napolitano, P.J. Schwartz Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers JAMA 292 2004 1341 1344
45. P.J. Schwartz, C. Spazzolini, S.G. Priori Who are the long-QT syndrome patients who receive an implantable cardioverter-defibrillator and what happens to them?: data from the European Long-QT Syndrome Implantable Cardioverter-Defibrillator (LQTS ICD) registry Circulation 122 2010 1272 1282
46. R.W. Sy, M.H. Gollob, G.J. Klein Arrhythmia characterization and long-term outcomes in catecholaminergic polymorphic ventricular tachycardia Heart Rhythm 8 2011 864 871
47. J.M. Horner, M.J. Ackerman Ventricular ectopy during treadmill exercise stress testing in the evaluation of long QT syndrome Heart Rhythm 5 2008 1690 1694
48. R. Rosso, J.M. Kalman, O. Rogowski Calcium channel blockers and beta-blockers versus beta-blockers alone for preventing exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia Heart Rhythm 4 2007 1149 1154
49. European Heart Rhythm Association, Heart Rhythm Society D.P. Zipes ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) J Am Coll Cardiol 48 2006 e247 e346
50. J.M. McLenaghan, E. Henderson, K.I. Morris, H.J. Dargie Ventricular arrhythmias in patients with hypertensive left ventricular hypertrophy N Engl J Med 317 1987 787 792
51. S.D. Pringle, F.G. Dunn, P.W. Macfarlane, J.H. McKillop, A.R. Lorimer, S.M. Cobbe Significance of ventricular arrhythmias in systemic hypertension with left ventricular hypertrophy Am J Cardiol 69 1992 913 917
52. A. Martinez-Rubio, Y. Schwammenthal, E. Schwammenthal Patients with valvular heart disease presenting with sustained ventricular tachyarrhythmias and syncope Results of programmed ventricular stimulation and long-term follow-up Circulation 96 1997 500 508
53. P. Kilgfield, D. Levy, R.B. Devreux, D.D. Savage Arrhythmias and sudden death in mitral valve prolapse Am Heart J 113 1987 1298 1307
54. F. Grigioni, M. Enriquez-Sarano, L.H. Ling Sudden death in mitral regurgitation due to flail leaflet J Am Coll Cardiol 34 1999 2078 2085
55. J.F. Avierinos, B.J. Gersh, L.J. Melton III Natural history of asymptomatic mitral valve prolapse in the community Circulation 106 2002 1355 1361
56. B.M. Scirica, E. Braunwald, L. Belardinelli Relationship between nonsustained ventricular tachycardia after non-ST-elevation acute coronary syndrome and sudden cardiac death: observations from the Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndrome-Thrombolysis in Myocardial Infarction 36 (MERLIN-TIMI 36) randomized controlled trial Circulation 122 2010 455 462
57. J.R. Harkness, D.A. Morrow, E. Braunwald Myocardial ischemia and ventricular tachycardia on continuous electrocardiographic monitoring and risk of cardiovascular outcomes after non-ST-segment elevation acute coronary syndrome (from the MERLIN-TIMI 36 trial) Am J Cardiol 108 2011 1373 1381
58. H. Heidbüchel, J. Tack, L. Vanneste, A. Ballet, H. Ector, F. Van de Werf Significance of arrhythmias during the first 24 hours of acute myocardial infarction treated with alteplase and effect of early administration of a beta-blocker or a bradycardiac agent on their incidence Circulation 89 1994 1051 1059
59. A.P. Maggioni, G. Zuanetti, M.G. Franzosi Prevalence and prognostic significance of ventricular arrhythmias after acute myocardial infarction in the fibrinolytic era: GISSI-2 results Circulation 87 1993 312 322
60. S.H. Hohnloser, T. Klingenheben, M. Zabel Prevalence, characteristics and prognostic value during long-term follow-up of nonsustained ventricular tachycardia after myocardial infarction in the thrombolytic era J Am Coll Cardiol 33 1999 1895 1902
61. M.T. La Rovere, G.D. Pinna, S.H. Hohnloser Autonomic tone and reflexes after myocardial infarction Baroreflex sensitivity and heart rate variability in the identification of patients at risk for life-threatening arrhythmias: implications for clinical trials Circulation 103 2001 2072 2077
62. D.E. Hofsten, K. Wachtell, B. Lund, H. Molgaard, K. Egstrup Prevalence and prognostic implications of non-sustained ventricular tachycardia in ST-segment elevation myocardial infarction after revascularization with either fibrinolysis or primary angioplasty Eur Heart J 28 2007 407 414
63. J.T. Bigger Jr., J.L. Fleiss, L.M. Rolnitzky Prevalence, characteristics and significance of ventricular tachycardia detected by 24-hour continuous electrocardiographic recordings in the late hospital phase of acute myocardial infarction Am J Cardiol 58 1986 1151 1160
64. C.L. Wolfe, C. Nibley, A. Bhandari, K. Chatterjee, M. Scheinman Polymorphous ventricular tachycardia associated with acute myocardial infarction Circulation 84 1991 1543 1551
65. G. Di Bella, C. Passino, G.D. Aquaro Different substrates of non-sustained ventricular tachycardia in post-infarction patients with and without left ventricular dilatation J Card Fail 16 2010 61 68
66. A.N. Cheema, K. Sheu, M. Parker, A.H. Kadish, J.J. Goldberger Nonsustained ventricular tachycardia in the setting of acute myocardial infarction: tachycardia characteristics and their prognostic implications Circulation 98 1998 2030 2036
67. Multicenter Post-Infarction Research Group Risk stratification and survival after myocardial infarction N Engl J Med 309 1983 331 336
68. J. Mukharji, R.E. Rude, W.K. Poole Risk factors for sudden death after acute myocardial infarction: two-year follow-up Am J Cardiol 54 1984 31 36
69. T.H. Makikallio, P. Barthel, R. Schneider Prediction of sudden cardiac death after acute myocardial infarction: role of Holter monitoring in the modern treatment era Eur Heart J 26 2005 762 769
70. L.A. Pires, M.H. Lehmann, A.E. Buxton, G.E. Hafley, K.L. Lee The Multicenter Unsustained Tachycardia Trial Investigators Differences in inducibility and prognosis of in-hospital versus out-of-hospital identified nonsustained ventricular tachycardia in patients with coronary artery disease: clinical and trial design implications J Am Coll Cardiol 38 2001 1156 1162
71. L.A. Pires, G.E. Hafley, K.L. Lee Prognostic significance of nonsustained ventricular tachycardia after coronary bypass surgery in patients with left ventricular dysfunction J Cardiovasc Electrophysiol 13 2002 757 763
72. S. Mittal, D.J. Lomnitz, S. Mirchandani Prognostic significance of nonsustained ventricular tachycardia after revascularization J Cardiovasc Electrophysiol 13 2002 342 346
73. A.M. Russo, G.E. Hafley, K.L. Lee Racial differences in outcome in the Multicenter Unsustained Tachycardia Trial (MUSTT): a comparison of whites versus blacks Circulation 108 2003 67 72
74. T. Furukawa, K. Moroe, H.N. Mayrovitz, R. Sampsell, R.J. Myerburg Arrhythmogenic effects of graded coronary blood flow reduction superimposed upon prior myocardial infarction in dogs Circulation 84 1991 368 377
75. H. Garan, J.M. McComb, J.N. Ruskin Spontaneous and electrically induced ventricular arrhythmias during acute ischemia superimposed on 2 week old canine myocardial infarction J Am Coll Cardiol 11 1988 603 611
76. A.J. Camm, D. Katritsis Risk stratification of patients with ventricular arrhythmias D.P. Zipes, J. Jalife, Clinical Electrophysiology: From Cell to Bedside 3rd edition 2000 Saunders Philadelphia, PA 808 827
77. A. Verma, B. Sarak, A.J. Kaplan Predictors of appropriate implantable cardioverter defibrillator (ICD) therapy in primary prevention patients with ischemic and nonischemic cardiomyopathy Pacing Clin Electrophysiol 33 2010 320 329
78. A.E. Buxton, K.L. Lee, G.E. Hafley Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease: lessons from the MUSTT study J Am Coll Cardiol 50 2007 1150 1157
79. F.J. Pastor-Pérez, S. Manzano-Fernández, R. Goya-Esteban Comparison of detection of arrhythmias in patients with chronic heart failure secondary to non-ischemic versus ischemic cardiomyopathy by 1 versus 7-day Holter monitoring Am J Cardiol 106 2010 677 681
80. S.N. Singh, R.D. Fletcher, S.G. Fisher Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure N Engl J Med 333 1995 77 82
81. Cardiac Arrhythmia Suppression Trial (CAST) Investigators Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction N Engl J Med 321 1989 406 412
82. Cardiac Arrhythmia Suppression Trial-II Investigators Effect of antiarrhythmic agent moricizine on survival after myocardial infarction The Cardiac Arrhythmia Suppression Trial-II N Engl J Med 327 1992 227 233
83. D.J. Wilber, B. Olshansky, J.F. Moran, P.J. Scanlon Electrophysiological testing and nonsustained ventricular tachycardia Use and limitations in patients with coronary artery disease and impaired ventricular function Circulation 82 1990 350 358
84. A.E. Buxton, K.L. Lee, L. DiCarlo Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death Multicenter Unsustained Tachycardia Trial Investigators N Engl J Med 342 2000 1937 1945
85. A.E. Buxton, K.L. Lee, G.E. Hafley Relation of ejection fraction and inducible ventricular tachycardia to mode of death in patients with coronary artery disease: an analysis of patients enrolled in the Multicenter Unsustained Tachycardia Trial Circulation 106 2002 2466 2472
86. H.V. Huikuri, J.M. Tapanainen, K. Lindgren Prediction of sudden cardiac death after myocardial infarction in the beta-blocking era J Am Coll Cardiol 42 2003 652 658
87. S.Z. Abildstrom, B.T. Jensen, E. Agner Heart rate versus heart rate variability in risk prediction after myocardial infarction J Cardiovasc Electrophysiol 14 2003 168 173
88. A. Bauer, P. Guzik, P. Barthel Reduced prognostic power of ventricular late potentials in post-infarction patients of the reperfusion era Eur Heart J 26 2005 755 761
89. K.M. Stein Noninvasive risk stratification for sudden death: signal-averaged electrocardiography, nonsustained ventricular tachycardia, heart rate variability, baroreflex sensitivity, and QRS duration Prog Cardiovasc Dis 51 2008 106 117
90. D.M. Bloomfield, R.C. Steinman, P.B. Namerow Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy: a solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II conundrum Circulation 110 2004 1885 1889
91. G. Amit, D.S. Rosenbaum, D.M. Super, O. Costantini Microvolt T-wave alternans and electrophysiologic testing predict distinct arrhythmia substrates: implications for identifying patients at risk for sudden cardiac death Heart Rhythm 7 2010 763 768
92. T. Chow, D.J. Kereiakes, J. Onufer Does microvolt T-wave alternans testing predict ventricular tachyarrhythmias in patients with ischemic cardiomyopathy and prophylactic defibrillators? The MASTER (Microvolt T Wave Alternans Testing for Risk Stratification of Post-Myocardial Infarction Patients) trial J Am Coll Cardiol 52 2008 1607 1615
93. O. Costantini, S.H. Hohnloser, M.M. Kirk The ABCD (Alternans Before Cardioverter Defibrillator) trial: strategies using T-wave alternans to improve efficiency of sudden cardiac death prevention J Am Coll Cardiol 53 2009 471 479
94. A.L. Waldo, A.J. Camm, H. deRuyter Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction The SWORD Investigators. Survival With Oral d-Sotalol Lancet 348 1996 7 12
95. J.A. Cairns, S.J. Connolly, M. Gent Post-myocardial infarction mortality in patients with ventricular premature depolarizations Circulation 84 1991 550 557
96. D.G. Julian, A.J. Camm, J. Frangin Randomised trial of effect of amiodarone on mortality in patients with left ventricular dysfunction after recent myocardial infarction: EMIAT Lancet 349 1997 662 663
97. M.V. Elizari, J.M. Martínez, C. Belziti Morbidity and mortality following early administration of amiodarone in acute myocardial infarction GEMICA Study Investigators, GEMA Group, Buenos Aires, Argentina. Grupo de Estudios Multicéntricos en Argentina Eur Heart J 21 2000 198 205
98. C.M. Viscoli, R.I. Horwitz, B.H. Singer Beta-blockers after myocardial infarction: influence of first-year clinical course on long-term effectiveness Ann Intern Med 118 1993 99 105
99. H.C. Doval, D.R. Nul, H.O. Grancelli Nonsustained ventricular tachycardia in severe heart failure Independent marker of increased mortality due to sudden death. GESICA-GEMA Investigators Circulation 94 1996 3198 3203
100. S.N. Singh, S.G. Fisher, P.E. Carson, R.D. Fletcher Prevalence and significance of nonsustained ventricular tachycardia in patients with premature ventricular contractions and heart failure treated with vasodilator therapy J Am Coll Cardiol 32 1998 942 947
101. T. Meinertz, T. Hofmann, W. Kasper Significance of ventricular arrhythmias in idiopathic dilated cardiomyopathy Am J Cardiol 53 1984 902 907
102. R. Neri, L. Mestroni, A. Salvi, F. Camerini Arrhythmias in dilated cardiomyopathy Postgrad Med J 62 1986 593 597
103. K.V. Olshausen, U. Stienen, F. Schwartz Long-term prognostic significance of ventricular arrhythmias in idiopathic dilated cardiomyopathy Am J Cardiol 61 1988 146 151
104. K. Soejima, W.G. Stevenson, J.L. Sapp, A.P. Selwyn, G. Couper, L.M. Epstein Endocardial and epicardial radiofrequency ablation of ventricular tachycardia associated with dilated cardiomyopathy: the importance of low-voltage scars J Am Coll Cardiol 43 2004 1834 1842
105. J.O. O'Neill, J.B. Young, C.E. Pothier Severe frequent ventricular ectopy after exercise as a predictor of death in patients with heart failure J Am Coll Cardiol 44 2004 820 826
106. M. Iacoviello, C. Forleo, P. Guida Ventricular repolarization dynamicity provides independent prognostic information toward major arrhythmic events in patients with idiopathic dilated cardiomyopathy J Am Coll Cardiol 50 2007 225 231
107. M. Zecchin, A. Di Lenarda, D. Gregori Are nonsustained ventricular tachycardias predictive of major arrhythmias in patients with dilated cardiomyopathy on optimal medical treatment? Pacing Clin Electrophysiol 31 2008 290 299
108. W. Grimm, J. Hoffmann, V. Menz Programmed ventricular stimulation for arrhythmia risk prediction in patients with idiopathic dilated cardiomyopathy and nonsustained ventricular tachycardia J Am Coll Cardiol 32 1998 739 745
109. E.S. Brilakis, W.K. Shen, S.C. Hammill Role of programmed ventricular stimulation and implantable cardioverter defibrillators in patients with idiopathic dilated cardiomyopathy and syncope Pacing Clin Electrophysiol 24 2001 1623 1630
110. J.P. Daubert, S.L. Winters, H. Subacius Ventricular arrhythmia inducibility predicts subsequent ICD activation in nonischemic cardiomyopathy patients: a DEFINITE substudy Pacing Clin Electrophysiol 32 2009 755 761
111. S. Rolf, W. Haverkamp, M. Borggrefe, G. Breithardt, D. Bocker Induction of ventricular fibrillation rather than ventricular tachycardia predicts tachyarrhythmia recurrences in patients with idiopathic dilated cardiomyopathy and implantable cardioverter defibrillator for secondary prophylaxis Europace 11 2009 289 296
112. L. Fauchier, D. Babuty, P. Cosnay Prognostic value of heart rate variability for sudden death and major arrhythmic events in patients with idiopathic dilated cardiomyopathy J Am Coll Cardiol 33 1999 1203 1207
113. E.J. Rashba, N.A. Estes, P. Wang Preserved heart rate variability identifies low-risk patients with nonischemic dilated cardiomyopathy: results from the DEFINITE trial Heart Rhythm 3 2006 281 286
114. G.H. Bardy, K.L. Lee, D.B. Mark Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure N Engl J Med 352 2005 225 237
115. L. Kober, C. Torp-Pedersen, J.J.V. McMurray Increased mortality after dronedarone therapy for severe heart failure N Engl J Med 358 2008 2678 2687
116. A.J. Moss, W.J. Hall, D.S. Cannom Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia Multicenter Automatic Defibrillator Implantation Trial Investigators N Engl J Med 335 1996 1933 1940
117. A.E. Buxton, K.L. Lee, J.D. Fisher A randomized study of the prevention of sudden death in patients with coronary artery disease Multicenter Unsustained Tachycardia Trial Investigators N Engl J Med 341 1999 1882 1890
118. I. Goldenberg, J. Gillespie, A.J. Moss Long-term benefit of primary prevention with an implantable cardioverter-defibrillator: an extended 8-year follow-up study of the Multicenter Automatic Defibrillator Implantation Trial II Circulation 122 2010 1265 1271
119. S.H. Hohnloser, K.H. Kuck, P. Dorian Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction N Engl J Med 351 2004 2481 2488
120. G. Steinbeck, D. Andresen, K. Seidl Defibrillator implantation early after myocardial infarction N Engl J Med 361 2009 1427 1436
121. A. Kadish, A. Dyer, J.P. Daubert Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy N Engl J Med 350 2004 2151 2157
122. S.A. Strickberger, J.D. Hummel, T.G. Bartlett Amiodarone versus implantable cardioverter-defibrillator:randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia - AMIOVIRT J Am Coll Cardiol 41 2003 1707 1712
123. D. Bänsch, M. Antz, S. Boczor Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the Cardiomyopathy Trial (CAT) Circulation 105 2002 1453 1458
124. P. Spirito, C. Rapezzi, C. Autore Prognosis of asymptomatic patients with hypertrophic cardiomyopathy and nonsustained ventricular tachycardia Circulation 90 1994 2743 2747
125. L. Monserrat, P.M. Elliott, J.R. Gimeno, S. Sharma, M. Penas-Lado, W.J. McKenna Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients J Am Coll Cardiol 42 2003 873 879
126. L. Fananapazir, S.E. Epstein Hemodynamic and electrophysiologic evaluation of patients with hypertrophic cardiomyopathy surviving cardiac arrest Am J Cardiol 67 1991 280 287
127. A.S. Adabag, B.J. Maron, E. Appelbaum Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance J Am Coll Cardiol 51 2008 1369 1374
128. G. Di Salvo, G. Pacileo, G. Limongelli Non sustained ventricular tachycardia in hypertrophic cardiomyopathy and new ultrasonic derived parameters J Am Soc Echocardiogr 23 2010 581 590
129. A.S. Adabag, S.A. Casey, M.A. Kuskowski, A.G. Zenovich, B.J. Maron Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy J Am Coll Cardiol 45 2005 697 704
130. R. O'Hanlon, A. Grasso, M. Roughton Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy J Am Coll Cardiol 56 2010 867 874
131. B.J. Maron Contemporary insights and strategies for risk stratification and prevention of sudden death in hypertrophic cardiomyopathy Circulation 121 2010 445 456
132. C. Basso, D. Corrado, F.I. Marcus Arrhythmogenic right ventricular cardiomyopathy Lancet 373 2009 1289 1300
133. D. Corrado, H. Calkins, M.S. Link Prophylactic implantable defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardia Circulation 122 2010 1144 1152
134. E. Arbelo, M.E. Josephson Ablation of ventricular arrhythmias in arrhythmogenic right ventricular dysplasia J Cardiovasc Electrophysiol 21 2010 473 486
135. L.T. Cooper Jr, G.J. Berry, R. Shabetai Idiopathic giant-cell myocarditis - natural history and treatment Multicenter Giant Cell Myocarditis Study Group Investigators N Engl J Med 336 1997 1860 1866
136. M.A. Gatzoulis, S. Balaji, S.A. Webber Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study Lancet 356 2000 975 981
137. P. Khairy, M.J. Landzberg, M.A. Gatzoulis Value of programmed ventricular stimulation after tetralogy of Fallot repair: a multicenter study Circulation 109 2004 1994 2000
138. P. Khairy, J. Aboulhosn, M.Z. Gurvitz Arrhythmia burden in adults with surgically repaired tetralogy of Fallot: a multi-institutional study Circulation 122 2010 868 875
139. G. Palladini, G. Malamani, F. Cò Holter monitoring in AL amyloidosis: prognostic implications Pacing Clin Electrophysiol 24 2001 1228 1233
140. S.L. Winters, M. Cohen, S. Greenberg Sustained ventricular tachycardia associated with sarcoidosis: assessment of the underlying cardiac anatomy and the prospective utility of programmed ventricular stimulation, drug therapy and an implantable antitachycardia device J Am Coll Cardiol 18 1991 937 943
141. A.V. Sarabanda, J.A. Marin-Neto Predictors of mortality in patients with Chagas' cardiomyopathy and ventricular tachycardia not treated with implantable cardioverter-defibrillators Pacing Clin Electrophysiol 34 2011 54 62
142. F.D. Munoz, F.F. Syed, A. Noheria Characteristics of premature ventricular complexes as correlates of reduced left ventricular systolic function: study of the burden, duration, coupling interval, morphology and site of origin of PVCs J Cardiovasc Electrophysiol 22 2011 791 798